Cancer Therapy News and Research

RSS

Hopkins researchers paint picture of cancer-promoting culprit

They say that a picture can be worth a thousand words. This especially is true for describing the structures of molecules that function to promote cancer.

7 Jan 2008

Down's syndrome gene protects against cancer

Researchers in the United States say the chromosomal abnormality that affects people with Down's syndrome also protects them against cancer.

3 Jan 2008

Hereditary form of colon cancer traced to common ancester in U.S.

A married couple who sailed from England to America around 1630 may be the ancestors of hundreds of people alive today who are at risk for a hereditary form of colon cancer.

3 Jan 2008

Barr receives approval for generic KYTRIL tablets

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Roche Laboratories Inc.'s KYTRIL (granisetron hydrochloride) Tablets, 1mg (eq to 1 mg base).

3 Jan 2008

Marital status doesn't affect lung cancer survival

Contrary to previous studies, married patients with lung cancer do not have longer survival, according to analysis of an extensive Mayo Clinic database in the December issue of "The Oncologist."

2 Jan 2008

FASgen announces new discoveries in lung cancer

FASgen is pleased to report the publication of important research results for lung cancer treatment using FAS093, one of the Company's proprietary compounds.

2 Jan 2008

Treating often ignored non-cancer health issues after cancer diagnosis prolongs survival

Receiving treatment for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates according to a study published in the December 20 issue of the Journal of Clinical Oncology.

28 Dec 2007

Study shows that antiangiogenic agent delays progression of advanced breast cancer

The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.

28 Dec 2007

Reconstruction surgery rarely discussed with breast cancer patients

A new study finds that most general surgeons do not discuss reconstruction with patients before surgical breast cancer treatment.

28 Dec 2007

New information about how normal cells and cancer cells survive under stress

Scientists report that an evolutionarily conserved transcription factor may have both positive and negative effects on the growth of tumors, depending on whether or not the tumor cells have enough oxygen.

28 Dec 2007

Bevacizumab found to improve survival for patients with advanced breast cancer

Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.

28 Dec 2007

Cancer stem cells may be at the root of brain tumors

Stem cells -- popularly known as a source of biological rejuvenation -- may play harmful roles in the body, specifically in the growth and spread of cancer. Amongst the wildly dividing cells of a tumor, scientists have located cancer stem cells.

27 Dec 2007

Microchip blood test detects cancers earlier

A new blood test which uses microchip technology may offer doctors the opportunity to detect cancers earlier and also monitor cancer treatment.

20 Dec 2007

Combo therapy reduces size of brain tumours

According to a major drug manufacturer, a combination drug treatment appears to be effective in fighting breast cancer that has spread to the brain.

19 Dec 2007

Scientists identify and repress breast cancer stem cells in mouse tissue

By manipulating highly specific gene-regulating molecules called microRNAs, scientists at Cold Spring Harbor Laboratory (CSHL) report that they have succeeded in singling out and repressing stem-like cells in mouse breast tissue - cells that are widely thought to give rise to cancer.

18 Dec 2007

Herceptin helps women with multiple chromosomes containing HER2 gene

The targeted therapy Herceptin helps women with HER2+ type of breast cancer independent of whether patients have extra copies of chromosome 17, home to the HER2 gene which produces the HER2 protein that fuels cancer growth.

17 Dec 2007

Sunitinib may be associated with cardiac toxicity

Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).

17 Dec 2007

Cancer research giants to present the CTRC-AACR San Antonio Breast Cancer Symposium

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio and the American Association for Cancer Research (AACR) has announced a collaboration for the future of the San Antonio Breast Cancer Symposium (SABCS).

14 Dec 2007

Discovery of key mechanism underlying idiopathic pulmonary fibrosis

A study led by Massachusetts General Hospital (MGH) researchers may have found a key mechanism underlying idiopathic pulmonary fibrosis (IPF), a usually fatal lung disease for which transplantation is the only successful treatment.

13 Dec 2007

Cancer stem cells may be cause of brain tumors

Expert available for comment on "Cancer Stem Cells" symposium at American Society of Hemotology (ASH) meeting, led by Dr. Andrew Schafer, chairman of medicine, NewYork-Presbyterian/Weill Cornell, and president, ASH.

13 Dec 2007